A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity.
Albu DI, Wolf BJ, Qin Y, Wang X, Daniel Ulumben A, Su M, Li V, Ding E, Angel Gonzalo J, Kong J, Jadhav R, Kuklin N, Visintin A, Gong B, Schuetz TJ.
Albu DI, et al. Among authors: wang x.
Oncoimmunology. 2024 Feb 16;13(1):2316945. doi: 10.1080/2162402X.2024.2316945. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38379869
Free PMC article.